These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 24980593)

  • 21. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment.
    Kanayama M; Hashimoto T; Shigenobu K; Yamane S; Bauer TW; Togawa D
    Spine (Phila Pa 1976); 2006 May; 31(10):1067-74. PubMed ID: 16648739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
    J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of 45S5 Bioactive Glass in A Standard Calcium Phosphate Collagen Bone Graft Substitute on the Posterolateral Fusion of Rabbit Spine.
    Pugely AJ; Petersen EB; DeVries-Watson N; Fredericks DC
    Iowa Orthop J; 2017; 37():193-198. PubMed ID: 28852357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up.
    Dai LY; Jiang LS
    Spine (Phila Pa 1976); 2008 May; 33(12):1299-304. PubMed ID: 18496340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
    Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
    Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.
    Pradhan BB; Bae HW; Dawson EG; Patel VV; Delamarter RB
    Spine (Phila Pa 1976); 2006 May; 31(10):E277-84. PubMed ID: 16648733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic bone graft versus autograft or allograft for spinal fusion: a systematic review.
    Buser Z; Brodke DS; Youssef JA; Meisel HJ; Myhre SL; Hashimoto R; Park JB; Tim Yoon S; Wang JC
    J Neurosurg Spine; 2016 Oct; 25(4):509-516. PubMed ID: 27231812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2005 Sep; 14(7):623-9. PubMed ID: 15672240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers.
    Glassman SD; Dimar JR; Burkus K; Hardacker JW; Pryor PW; Boden SD; Carreon LY
    Spine (Phila Pa 1976); 2007 Jul; 32(15):1693-8. PubMed ID: 17621221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes.
    Resnick DK; Choudhri TF; Dailey AT; Groff MW; Khoo L; Matz PG; Mummaneni P; Watters WC; Wang J; Walters BC; Hadley MN;
    J Neurosurg Spine; 2005 Jun; 2(6):733-6. PubMed ID: 16028744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion.
    Glassman SD; Dimar JR; Carreon LY; Campbell MJ; Puno RM; Johnson JR
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1694-8. PubMed ID: 16094268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion.
    Glassman SD; Carreon LY; Campbell MJ; Johnson JR; Puno RM; Djurasovic M; Dimar JR
    Spine J; 2008; 8(3):443-8. PubMed ID: 17526436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
    Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
    J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of demineralized bone matrices for spinal fusion: the evidence for efficacy.
    Aghdasi B; Montgomery SR; Daubs MD; Wang JC
    Surgeon; 2013 Feb; 11(1):39-48. PubMed ID: 23040457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from 2002 to 2008.
    Dagostino PR; Whitmore RG; Smith GA; Maltenfort MG; Ratliff JK
    Spine J; 2014 Jan; 14(1):20-30. PubMed ID: 23218827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healos and bone marrow aspirate used for lumbar spine fusion: a case controlled study comparing healos with autograft.
    Neen D; Noyes D; Shaw M; Gwilym S; Fairlie N; Birch N
    Spine (Phila Pa 1976); 2006 Aug; 31(18):E636-40. PubMed ID: 16915079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and radiographic outcomes of concentrated bone marrow aspirate with allograft and demineralized bone matrix for posterolateral and interbody lumbar fusion in elderly patients.
    Ajiboye RM; Hamamoto JT; Eckardt MA; Wang JC
    Eur Spine J; 2015 Nov; 24(11):2567-72. PubMed ID: 26169879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
    Glassman SD; Carreon LY; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2843-9. PubMed ID: 19092613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
    Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
    Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoinductive bone graft substitutes for lumbar fusion: a systematic review.
    Agarwal R; Williams K; Umscheid CA; Welch WC
    J Neurosurg Spine; 2009 Dec; 11(6):729-40. PubMed ID: 19951027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.